We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
This document outlines the code of conduct that all Public Health England (PHE) staff must abide by.
Report outlining the Medicines and Healthcare products Regulatory Agency’s (MHRA's) commitment to burden reduction activity.
The agenda and papers available for the Public Health England Board meeting of 25 May 2016.
This register of interests records those interests that members of PHE committee's hold outside the agency.
Letter from Jane Ellison MP confirming the role the government expects PHE to play in the health and care system in 2016 to 2017.
The agenda and papers available for the Public Health England Board meeting of 27 April 2016.
Documents outlining the Medicines and Healthcare products Regulatory Agency’s strategic direction for 2013-18 including our mission, aims, and objectives for this five year period.
Details of Public Health England transactions over £25,000 in February 2016.
Details of PHE's government procurement card expenditure over £500.
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between October and December 2015 (quarter 3).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between July and September 2015 (quarter 2).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between January and March 2015 (quarter 4).
Business expenses incurred by Medicines and Healthcare products Regulatory Agency (MHRA) board members between October and December 2014 (quarter 3).
Explains what PHE's South East centre does to protect and improve the region's health and wellbeing, and to reduce inequalities.
Percentage of invoices to Public Health England paid within 5, 10 and 30 working days of receipt, from April 2015 onward.
The agenda and papers available for the Public Health England Board meeting of 23 March 2016.
The agenda and papers available for the Public Health England Board meeting of 24 February 2016.
How PHE met the public sector equality duty in 2015.
These documents provide a short and long versions of Ipsos MORI's report, along with a short film about the results.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).